ea0070ep362 | Pituitary and Neuroendocrinology | ECE2020
Alikhanian Inga
, Grineva Elena
, Tsoy Uliana
, Belousova Lidiya
, Dalmatova Anna
, Cherebillo Vladislav
, Gussaova Natalia
Introduction: Prolactinomas are the most common pituitary adenomas. Dopamine agonists (DAs) are the treatment of choice for prolactinomas. Patients with prolactinomas normally are treated in ambulatory. In some patients there are challenges in therapy, and they need to be hospitalized.Objective: To study the clinical features and outcomes of in-patients with prolactinoma.Materials and methods: A retrospective analysis of 40 hospita...